These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 37517458)

  • 1. A population-based survey of self-reported delays in breast, cervical, colorectal and lung cancer screening.
    Gunn CM; Berrian K; Weiss JE; Tosteson AAN; Hasson RM; Di Florio-Alexander R; Peacock JL; Rees JR
    Prev Med; 2023 Oct; 175():107649. PubMed ID: 37517458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
    Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
    Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparities in access to breast, colorectal, and cervical cancer screening programmes have intensified during the pandemic period. Findings of a health equity audit conducted by the Pavia Healthcare Protection Agency (Lombardy Region, Northern Italy).
    Girardi D; Vecchio R; Tanious M; Cacitti S; Ancarani C; Dalle Carbonare S; Perotti P; Bonafede C; Cavallo R; Gentile L; Parrini A; Lucente EM; Carlesso A; Cadum E; Cecconami L; Odone A; Deandrea S
    Epidemiol Prev; 2024; 48(2):130-139. PubMed ID: 38770730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Screening Disparities Before and After the COVID-19 Pandemic.
    Lofters AK; Wu F; Frymire E; Kiran T; Vahabi M; Green ME; Glazier RH
    JAMA Netw Open; 2023 Nov; 6(11):e2343796. PubMed ID: 37983033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
    Joung RH; Nelson H; Mullett TW; Kurtzman SH; Shafir S; Harris JB; Yao KA; Brajcich BC; Bilimoria KY; Cance WG
    Cancer; 2022 Jun; 128(11):2119-2125. PubMed ID: 35307815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Cancer Screening in the US During the COVID-19 Pandemic.
    Fedewa SA; Star J; Bandi P; Minihan A; Han X; Yabroff KR; Jemal A
    JAMA Netw Open; 2022 Jun; 5(6):e2215490. PubMed ID: 35657622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
    Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women.
    Charkhchi P; Schabath MB; Carlos RC
    J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405
    [No Abstract]   [Full Text] [Related]  

  • 9. Modifiers of Cancer Screening Prevention Among Sexual and Gender Minorities in the Behavioral Risk Factor Surveillance System.
    Charkhchi P; Schabath MB; Carlos RC
    J Am Coll Radiol; 2019 Apr; 16(4 Pt B):607-620. PubMed ID: 30947895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in cancer screening process in primary care during the covid-19 pandemic.
    Atadağ YB; Türkmen AT; Öksüz A; Keten HS; Aydin MR
    Saudi Med J; 2023 Jun; 44(6):621-624. PubMed ID: 37343993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. County-Level Social Vulnerability and Breast, Cervical, and Colorectal Cancer Screening Rates in the US, 2018.
    Bauer C; Zhang K; Xiao Q; Lu J; Hong YR; Suk R
    JAMA Netw Open; 2022 Sep; 5(9):e2233429. PubMed ID: 36166230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Neighborhood Measures of Social Determinants of Health With Breast, Cervical, and Colorectal Cancer Screening Rates in the US Midwest.
    Kurani SS; McCoy RG; Lampman MA; Doubeni CA; Finney Rutten LJ; Inselman JW; Giblon RE; Bunkers KS; Stroebel RJ; Rushlow D; Chawla SS; Shah ND
    JAMA Netw Open; 2020 Mar; 3(3):e200618. PubMed ID: 32150271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between sociodemographic factors and breast, cervical, and colorectal cancer screening in the United States.
    Mondragón Márquez LI; Domínguez Bueso DL; González Ruiz LM; Liu JJ
    Cancer Causes Control; 2023 Dec; 34(12):1073-1084. PubMed ID: 37486400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia.
    Nickson C; Smith MA; Feletto E; Velentzis LS; Broun K; Deij S; Grogan P; Hall M; He E; St John DJ; Lew JB; Procopio P; Simms KT; Worthington J; Mann GB; Canfell K
    Elife; 2023 Apr; 12():. PubMed ID: 37022767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing breast, cervical, and colorectal cancer screening among rural women: Baseline characteristics of a randomized control trial.
    Biederman E; Baltic R; Katz ML; Rawl S; Vachon E; Monahan PO; Stump TE; Kettler C; Carter L; Young G; Xu W; Paskett ED; Champion V
    Contemp Clin Trials; 2022 Dec; 123():106986. PubMed ID: 36328234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of health insurance coverage on breast, cervical, and colorectal cancer screening in rural primary care settings.
    Carney PA; O'Malley J; Buckley DI; Mori M; Lieberman DA; Fagnan LJ; Wallace J; Liu B; Morris C
    Cancer; 2012 Dec; 118(24):6217-25. PubMed ID: 22648383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant Women.
    Taksler GB; Peterse EFP; Willems I; Ten Haaf K; Jansen EEL; de Kok IMCM; van Ravesteyn NT; de Koning HJ; Lansdorp-Vogelaar I
    JAMA Oncol; 2021 Jun; 7(6):885-894. PubMed ID: 33914025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the role of access in Hispanic cancer screening disparities.
    Spencer JC; Noel L; Shokar NK; Pignone MP
    Cancer; 2023 May; 129(10):1569-1578. PubMed ID: 36787126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the coverage of cervical and breast cancer screening among women aged 35-69 years and related impact of socioeconomic factors in China, 2013].
    Bao HL; Wang LH; Wang LM; Fang LW; Zhang M; Zhao ZP; Cong S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):208-212. PubMed ID: 29495207
    [No Abstract]   [Full Text] [Related]  

  • 20. Japanese cancer screening programs during the COVID-19 pandemic: Changes in participation between 2017-2020.
    Machii R; Takahashi H
    Cancer Epidemiol; 2023 Feb; 82():102313. PubMed ID: 36508964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.